in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
138 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />
❚ prote<strong>in</strong>-SERINE/THREONINE k<strong>in</strong>ases [AGC]<br />
GRK2 (ADRBK1)<br />
Ref. 2200<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
Comprehensive k<strong>in</strong>ase profile<br />
Source<br />
human recomb<strong>in</strong>ant (<strong>in</strong>sect cells)<br />
Substrate ATP + His-tagged Rb truncated prote<strong>in</strong><br />
(140 nM)<br />
Measured product phospho-His-tagged Rb truncated prote<strong>in</strong><br />
Detection method HTRF<br />
Reference<br />
staurospor<strong>in</strong>e (IC 50 : 50 nM)<br />
Laccar<strong>in</strong>o, G. et al. (2005) Eur. Heart. J., 26: 1752-1758.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
GRK3/BARK2 (ADRBK2)<br />
Ref. 2627<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
Comprehensive k<strong>in</strong>ase profile<br />
Source<br />
human recomb<strong>in</strong>ant<br />
Substrate ATP + Ulight-ARTKQTARKSTGGKAPRKQLAGCG<br />
(25 nM)<br />
Measured product phospho-Ulight-ARTKQTARKSTGGKAPRKQL<br />
AGCG<br />
Detection method LANCE<br />
Reference<br />
staurospor<strong>in</strong>e (IC 50 : 295 nM)<br />
Luo, J. and Benovic, J.L. (2003) J. Biol. Chem., 278: 50908-50914.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
GRK5<br />
Ref. 2020<br />
Q 3 weeks<br />
Source<br />
human recomb<strong>in</strong>ant (<strong>in</strong>sect cells)<br />
Substrate ATP + biot<strong>in</strong>yl-KKKKERLLDDRHDSGLDSMKDEE<br />
(600 nM)<br />
Measured product phospho-biot<strong>in</strong>yl-KKKKERLLDDRHDSGLDSKDEE<br />
Detection method HTRF<br />
Reference<br />
staurospor<strong>in</strong>e (IC 50 : 27 nM)<br />
Kunapuli, P. et al. (1994) J. Biol. Chem., 269: 1099-1106.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
MRCKa<br />
Ref. 2629<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Comprehensive k<strong>in</strong>ase profile<br />
Source<br />
human recomb<strong>in</strong>ant<br />
Substrate ATP + Ulight-ARTKQTARKSTGGKAPRKQLAGCG<br />
(75 nM)<br />
Measured product phospho-Ulight-ARTKQTARKSTGGKAPRKQL<br />
AGCG<br />
Detection method LANCE<br />
Reference staurospor<strong>in</strong>e (IC 50 : 18 nM)<br />
Tan, I. et al. (2001) Mol. Cell. Biol., 21: 2767-2778.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
selected cerep assays<br />
❚ Biochemical k<strong>in</strong>ase assays<br />
<br />
<br />
<br />
<br />
<br />
<br />
K<strong>in</strong>ase assays are enzymatic assays mostly us<strong>in</strong>g activated k<strong>in</strong>ases. Those are usually full length k<strong>in</strong>ase or cytoplasmic doma<strong>in</strong> of RTK.<br />
Assays are designed to be as close as possible to ATP and substrate Km.<br />
<br />
The technology used to measure substrate phosphorylation is TR-FRET (HTRF ® or LANCE ® ). A few assays are cascade of activation.<br />
❚ Cellular k<strong>in</strong>ase assays<br />
<br />
In order to complement our exist<strong>in</strong>g biochemical assay platform, we have implemented cellular k<strong>in</strong>ase assays. These assays allow to<br />
confirm <strong>in</strong>hibitors activity <strong>in</strong> a relevant cellular background and profile their selectivity aga<strong>in</strong>st multiple signal<strong>in</strong>g pathways.<br />
- Cellular k<strong>in</strong>ase phosphorylation assays<br />
Cellular k<strong>in</strong>ase phosphorylation assays are developed us<strong>in</strong>g AlphaScreen ® Surefire ® assay kits. The assays are optimized for directly<br />
measur<strong>in</strong>g k<strong>in</strong>ase activation follow<strong>in</strong>g treatment of cells with activators of signal<strong>in</strong>g pathways.<br />
- Cellular tyros<strong>in</strong>e k<strong>in</strong>ase receptor activity assays<br />
We have demonstrated that the impedance-based technology can be used to monitor the activity of the ma<strong>in</strong> tyros<strong>in</strong>e k<strong>in</strong>ase receptor<br />
families. These label-free assays allow the identification of <strong>in</strong>hibitors target<strong>in</strong>g either the ligand b<strong>in</strong>d<strong>in</strong>g doma<strong>in</strong> or the k<strong>in</strong>ase doma<strong>in</strong>.<br />
These assays can be developed <strong>in</strong> virtually any cancer cell l<strong>in</strong>es or primary cells. As an example, we have developed and validated<br />
the EGFR cellular assay <strong>in</strong> the follow<strong>in</strong>g cancer cell l<strong>in</strong>es: A431, HELA and MDA-MB-231.<br />
❚ B<strong>in</strong>d<strong>in</strong>g k<strong>in</strong>ase assays<br />
See page 107.